Nearly 1 in 10 (8%) people with glaucoma surveyed in the UK say COVID-19 has prevented them from managing their condition as normal during the pandemic
[1]
Almost a third (29%) people with glaucoma surveyed in the UK who use prescription eye drops to manage their condition, report not using them as frequently as prescribed
[1]
[2]
People with glaucoma have struggled to access their healthcare treatment during the COVID-19 pandemic, putting them at risk of vision loss and blindness, according to results of a new European survey of 2,010 adults with glaucoma, including 250 UK respondents.* Glaucoma is an eye condition that affects about two per cent of the population over 40 in the UK